Abstract
Suboptimal pharmaceutical drug performance remains a critical issue in healthcare, contributing to preventable mortality, morbidity, and economic burden. Despite advancements in drug development, a...
Funding Information
  • National Institutes of Health (5R01EB032910 and 5R01DK126739-4)

This publication has 24 references indexed in Scilit: